FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100169525> ?p ?o ?g. }

• W2100169525 abstract "Background Intravenous broad–spectrum antibiotics are indicated for the treatment of severe infections. However, the emergence of infections caused by multiple‐drug resistant organisms in conjunction with a lack of novel antibiotics has prompted the investigation of alternative dosing strategies to improve clinical efficacy and tolerability. To optimise pharmacokinetic and pharmacodynamic antibiotic parameters, continuous antibiotic infusions have been compared with traditional intermittent antibiotic infusions. Objectives To compare the clinical efficacy and safety of continuous intravenous administration of concentration–dependent and time–dependent antibiotics with traditional intermittent intravenous administration in adults with severe acute bacterial infections. Search methods The following electronic databases were searched in September 2012: The Cochrane Injuries Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), The Cochrane Library, MEDLINE (OvidSP), EMBASE (OvidSP), CINAHL, ISI Web of Science: Science Citation Index Expanded (SCI‐EXPANDED), and ISI Web of Science: Conference Proceedings Citation Index‐Science (CPCI‐S). The reference lists of all relevant materials, the Internet, and the trials registry www.clinicaltrials.gov for completed and ongoing trials were also searched. Selection criteria Randomised controlled trials in adults with a bacterial infection requiring intravenous antibiotic therapy comparing continuous versus intermittent infusions of antibiotics were included. Both time–dependent and concentration–dependent antibiotics were considered. Data collection and analysis Three independent authors performed data extraction for the included studies. All data were cross–checked and disagreements resolved by consensus. An intention‐to‐treat analysis was conducted using a random–effects model. Main results Twenty–nine studies met inclusion criteria with a combined total of more than 1600 participants. Most included studies were judged to be at unclear or high risk of bias with regard to randomisation sequence generation, allocation concealment, blinding, management of incomplete outcome data, selective outcome reporting, and other potential threats to validity. No studies were judged to be at low risk of bias for all methodological quality items assessed. No differences in all–cause mortality (n = 1241, risk ratio (RR) 0.89, 95% confidence interval (CI) 0.67 to 1.20, P = 0.45), infection recurrence (n = 398, RR 1.22, 95% CI 0.35 to 4.19, P = 0.76), clinical cure (n = 975, RR 1.00, 95% CI 0.93 to 1.08, P = 0.98), and super‐infection post–therapy (n = 813, RR 1.08, 95% CI 0.60 to 1.94, P = 0.79) were reported, nor were any differences observed in safety outcomes, including adverse events (n = 575, RR 1.02, 95% CI 0.94 to 1.12, P = 0.63), serious adverse events (n = 871, RR 1.36, 95% CI 0.80 to 2.30, P = 0.26), and withdrawals due to adverse events (n = 871, RR 2.03, 95% CI 0.52 to 7.95, P = 0.31). A difference was observed in subgroup analyses of clinical cure in septic versus non‐septic participants, in which intermittent antibiotic infusions were favoured for clinical cure in septic participants. However, this effect was not consistent between random‐effects and fixed‐effect analyses. No differences were noted in the sensitivity analyses conducted. Authors' conclusions No differences in mortality, infection recurrence, clinical cure, super‐infection post–therapy, and safety outcomes were reported when continuous infusions of intravenous antibiotics were compared with traditional intermittent infusions of antibiotics. However, the wide confidence intervals suggest that beneficial or harmful effects cannot be ruled out for all outcomes. Therefore, the current evidence is insufficient to recommend the widespread adoption of continuous infusion antibiotics in the place of intermittent infusions of antibiotics. Additinal large prospective randomised trials, with consistent and complete reporting of clinical outcome measures, conducted with concurrent pharmacokinetic and pharmacodynamic studies in special populations, are required to determine whether adoption of continuous antibiotic infusions is warranted in specific circumstances." @default.
• W2100169525 created "2016-06-24" @default.
• W2100169525 creator A5011643664 @default.
• W2100169525 creator A5038686339 @default.
• W2100169525 creator A5052392581 @default.
• W2100169525 creator A5091546307 @default.
• W2100169525 date "2013-03-28" @default.
• W2100169525 modified "2023-10-17" @default.
• W2100169525 title "Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections" @default.
• W2100169525 cites W135678348 @default.
• W2100169525 cites W1520193286 @default.
• W2100169525 cites W1598602811 @default.
• W2100169525 cites W1699591744 @default.
• W2100169525 cites W1838962315 @default.
• W2100169525 cites W1892658174 @default.
• W2100169525 cites W1968688595 @default.
• W2100169525 cites W1976771130 @default.
• W2100169525 cites W1980701181 @default.
• W2100169525 cites W1990297164 @default.
• W2100169525 cites W1992203366 @default.
• W2100169525 cites W1996266827 @default.
• W2100169525 cites W1996490853 @default.
• W2100169525 cites W1998410651 @default.
• W2100169525 cites W2001283831 @default.
• W2100169525 cites W2005117246 @default.
• W2100169525 cites W2007862655 @default.
• W2100169525 cites W2012344876 @default.
• W2100169525 cites W2014460727 @default.
• W2100169525 cites W2016408145 @default.
• W2100169525 cites W2016888150 @default.
• W2100169525 cites W2020022801 @default.
• W2100169525 cites W2023138825 @default.
• W2100169525 cites W2023577756 @default.
• W2100169525 cites W2025760535 @default.
• W2100169525 cites W2028964482 @default.
• W2100169525 cites W2031625154 @default.
• W2100169525 cites W2033080849 @default.
• W2100169525 cites W2037321268 @default.
• W2100169525 cites W2041912468 @default.
• W2100169525 cites W2043159296 @default.
• W2100169525 cites W2043684467 @default.
• W2100169525 cites W2046122459 @default.
• W2100169525 cites W2054104317 @default.
• W2100169525 cites W2057226149 @default.
• W2100169525 cites W2057650704 @default.
• W2100169525 cites W2057779731 @default.
• W2100169525 cites W2058974499 @default.
• W2100169525 cites W2062138891 @default.
• W2100169525 cites W2064012638 @default.
• W2100169525 cites W2066745723 @default.
• W2100169525 cites W2073897734 @default.
• W2100169525 cites W2079691262 @default.
• W2100169525 cites W2079827630 @default.
• W2100169525 cites W2084978147 @default.
• W2100169525 cites W2085752417 @default.
• W2100169525 cites W2085793991 @default.
• W2100169525 cites W2093603669 @default.
• W2100169525 cites W2097898411 @default.
• W2100169525 cites W2098667568 @default.
• W2100169525 cites W2099925865 @default.
• W2100169525 cites W2100018294 @default.
• W2100169525 cites W2100169525 @default.
• W2100169525 cites W2100510403 @default.
• W2100169525 cites W2103417287 @default.
• W2100169525 cites W2103812628 @default.
• W2100169525 cites W2104675861 @default.
• W2100169525 cites W2104779095 @default.
• W2100169525 cites W2112790784 @default.
• W2100169525 cites W2113717321 @default.
• W2100169525 cites W2114231217 @default.
• W2100169525 cites W2114671887 @default.
• W2100169525 cites W2118905287 @default.
• W2100169525 cites W2120963228 @default.
• W2100169525 cites W2123412553 @default.
• W2100169525 cites W2125435699 @default.
• W2100169525 cites W2126184332 @default.
• W2100169525 cites W2130070772 @default.
• W2100169525 cites W2130292873 @default.
• W2100169525 cites W2130761171 @default.
• W2100169525 cites W2132491970 @default.
• W2100169525 cites W2135190942 @default.
• W2100169525 cites W2135400982 @default.
• W2100169525 cites W2140467366 @default.
• W2100169525 cites W2141173497 @default.
• W2100169525 cites W2143024482 @default.
• W2100169525 cites W2143150107 @default.
• W2100169525 cites W2144847708 @default.
• W2100169525 cites W2149784817 @default.
• W2100169525 cites W2151174719 @default.
• W2100169525 cites W2158308518 @default.
• W2100169525 cites W2160331061 @default.
• W2100169525 cites W2165901639 @default.
• W2100169525 cites W2171879266 @default.
• W2100169525 cites W2182682701 @default.
• W2100169525 cites W2271790809 @default.
• W2100169525 cites W2588681363 @default.
• W2100169525 cites W28522926 @default.
• W2100169525 cites W2916841405 @default.
• W2100169525 cites W2991814125 @default.
• W2100169525 cites W4243499919 @default.

• next